Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.

Details

Language :

English

ISSN :

00070920

Volume :

114

Issue :

12

Database :

Academic Search Index

Journal :

British Journal of Cancer

Publication Type :

Academic Journal

Accession number :

116145346

Full Text :

https://doi.org/10.1038/bjc.2016.133